论文部分内容阅读
目的:回顾性分析我院采用喜炎平联合思密达治疗小儿腹泻的疗效情况。方法:98例小儿腹泻患者随机分为观察组和对照组,两组均为49例,分别采用口服思密达加静脉滴注喜炎平治疗和静脉滴注利巴韦林加口服鞣酸蛋白治疗。结果:观察组患者的平均止泻时间明显少于对照组患者(P<0.05),观察组患者的治疗的总有效明显高于对照组患者(P<0.05),两组患儿在治疗过程中均未见明显不良反应发生。结论:喜炎平联合思密达治疗小儿腹泻具有较好的疗效,值得在临床中推广应用。
Objective: To retrospectively analyze the efficacy of Xiyanping combined with Smecta in the treatment of children with diarrhea. Methods: 98 cases of children with diarrhea were randomly divided into observation group and control group, both groups were 49 cases, respectively, oral administration of Smecta and Xiyanping intravenous infusion of ribavirin plus oral tannic acid protein treatment. Results: The average antidiarrheal time in the observation group was significantly less than that in the control group (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group (P <0.05) No obvious adverse reactions occurred. Conclusion: Xiyanping combined with Smectite treatment of children with diarrhea has a good effect, it is worth to promote the clinical application.